JP Morgan Call 210 PSX 16.01.2026/ DE000JK7LVR8 /
6/19/2024 9:12:31 AM | Chg.-0.050 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.760EUR | -6.17% | - Bid Size: - |
- Ask Size: - |
Phillips 66 | 210.00 USD | 1/16/2026 | Call |
GlobeNewswire
6/17
Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
6/17
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
6/12
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
6/5
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
5/22
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
5/20
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
5/16
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
5/16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
5/15
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire
5/14
Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...
GlobeNewswire
5/13
Safe Boating Campaign’s Annual National Safe Boating Week Celebrates All Boaters This May 18-24, 202...
GlobeNewswire
5/10
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Marke...
GlobeNewswire
5/9
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...